Zhitong Finance App News, Zhifei Biotech (300122.SZ) issued an announcement. The company recently learned that the freeze-dried human rabies vaccine (ZFB-3 cells) developed by its wholly-owned subsidiary Anhui Zhifeilong Koma Biopharmaceutical Co., Ltd. (“ZFB-3 cells”) has obtained the China Drug Clinical Trial Approval Notice (Notice Number: 2026LP03473) and agreed to carry out clinical trials to prevent rabies.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Zhifei Biotech (300122.SZ) issued an announcement. The company recently learned that the freeze-dried human rabies vaccine (ZFB-3 cells) developed by its wholly-owned subsidiary Anhui Zhifeilong Koma Biopharmaceutical Co., Ltd. (“ZFB-3 cells”) has obtained the China Drug Clinical Trial Approval Notice (Notice Number: 2026LP03473) and agreed to carry out clinical trials to prevent rabies.